HealthCor Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

HealthCor Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-9,170	Closed	-$1.43M	–	65
2022 Q1	$1.43M	Sell	9,170 -339,910	-97%	-$49.3M	0.1%	55
2021 Q4	$44.5M	Sell	349,080 -111,710	-24%	-$14.7M	2.42%	15
2021 Q3	$60M	Buy	+460,790	New	+$69.6M	2.59%	14
2015 Q2	–	Sell	-325,000	Closed	-$56.2M	–	67
2015 Q1	$56.2M	Buy	+325,000	New	+$55.8M	2.68%	12
2014 Q3	–	Sell	-277,000	Closed	-$40.7M	–	56
2014 Q2	$40.7M	Buy	+277,000	New	+$38.4M	2.04%	23
2013 Q3	–	Sell	-250,000	Closed	-$17.2M	–	64
2013 Q2	$17.2M	Buy	+250,000	New	+$15.3M	1.04%	29

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

HealthCor Management's JAZZ Position: Q2 2022 in Review

HealthCor Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2022, closing a stake of 9,170 shares — an estimated $1.43M sold.

HealthCor Management first reported a position in JAZZ in Q2 2013 and held it in 6 quarters. The position peaked at $60M in Q3 2021. 468 funds tracked by Wall St. Rank hold JAZZ as of Q2 2022.

HealthCor Management reported no remaining Jazz Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
HealthCor Management sold 9,170 Jazz Pharmaceuticals shares in Q2 2022, an estimated $1.43M.
HealthCor Management first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 6 quarters.
HealthCor Management's Jazz Pharmaceuticals position peaked at $60M in Q3 2021.
468 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2022.

Based on HealthCor Management's 13F filing for Q2 2022, filed 15 Aug 2022.